Description de l'entreprise
SKAN is a Swiss company and a global market and technological leader for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN’s core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. Furthermore, the company offers its customers process support, services, and consumables.
Conseil d'administration & Conseil de surveillance
| PDG |
| Thomas Huber |
| Conseil d'administration |
| Burim Maraj, Philippe Jérôme, Dr. Sascha Pawel, Marina Häni, Martin E. Steegmüller, Thomas Zinn, Ralf Krämer, Maria Cuevas Otero, Cornelia Henny-Weiss |
| Conseil de surveillance |
| Beat Lüthi, Cornelia Gehrig, Oliver Baumann, Thomas Huber, Gregor Plattner, Patrick Schär |
Données de l'entreprise
| Nom: |
SKAN N |
| Adresse: |
Kreuzstrasse 5,4123 Allschwil |
| Téléphone: |
+41 61 485 44 44 |
| Fax: |
- |
| Courriel: |
info@skan.com
|
| Internet: |
https://skan.com/en/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
44.12% |
| IPO date: |
28/10/2021 |
Relations avec les investisseurs
| Nom: |
Thomas Balmer / Alexandre Müller |
| Téléphone IR: |
+41 43 268 32 32 |
| IR-Fax: |
- |
| E-mail IR: |
ir@skan.com
|
